Skip to main content
BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
110.23
+1.43 (1.31%)
At close: Feb 27, 2026, 4:00 PM EST
111.00
+0.77 (0.70%)
After-hours: Feb 27, 2026, 6:00 PM EST

BioNTech SE Revenue

BioNTech SE had revenue of 1.52B EUR in the quarter ending September 30, 2025, with 22.02% growth. This brings the company's revenue in the last twelve months to 3.15B, up 3.70% year-over-year. In the year 2024, BioNTech SE had annual revenue of 2.75B, down -27.96%.

Revenue (ttm)
3.15B EUR
Revenue Growth
+3.70%
P/S Ratio
7.48
Revenue / Employee
465,520 EUR
Employees
6,772
Market Cap
27.66B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.75B-1.07B-27.96%
Dec 31, 20233.82B-13.49B-77.94%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020482.30M373.70M344.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BeOne Medicines AG 5.34B
Incyte 5.14B
argenx SE 4.25B
Genmab 3.72B
Alnylam Pharmaceuticals 3.71B
Royalty Pharma 2.38B
Moderna 1.94B
Ascendis Pharma 845.52M
Revenue Rankings

BNTX News

More News